Imaging spectrum of immunomodulating, chemotherapeutic and radiation therapy-related intracranial effects

Christie M. Lincoln, Peter Fata, Susan Sotardi, Michael Pohlen, Tomas Uribe, Jacqueline A. Bello

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Objective: A wide range of treatment-related side effects result in specific neurologic symptoms and signs and neuroimaging features. Even to the most seasoned neuroradiologist, elucidating therapy-related side effects from other common mimics can be challenging. We provide a pictorial survey of some common and uncommon medication-induced and therapy-related neuroimaging manifestations, discuss pathophysiology and common pitfalls in imaging and diagnosis. Methods: A case-based review is utilized to depict scenarios on a routine basis in a general radiology or neuroradiology practice such as medication-induced posterior reversible encephalopathy syndrome to the more challenging cases of pseudoprogression and pseudoregression in temozolmide and bevacizumab therapy in gliobastoma treatment protocols. Conclusion: Knowledge of the treatment-induced imaging abnormalities is essential in the accurate interpretation and diagnosis from the most routine to most challenging of clinical situations. We provide a pictorial review for the radiologist to employ in order to be an invaluable provider to our clinical colleagues and patients.

Original languageEnglish (US)
Article number20170553
JournalBritish Journal of Radiology
Volume91
Issue number1082
DOIs
StatePublished - Jan 1 2018

Fingerprint

Radiotherapy
Neuroimaging
Posterior Leukoencephalopathy Syndrome
Therapeutics
Clinical Protocols
Neurologic Manifestations
Radiology

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Imaging spectrum of immunomodulating, chemotherapeutic and radiation therapy-related intracranial effects. / Lincoln, Christie M.; Fata, Peter; Sotardi, Susan; Pohlen, Michael; Uribe, Tomas; Bello, Jacqueline A.

In: British Journal of Radiology, Vol. 91, No. 1082, 20170553, 01.01.2018.

Research output: Contribution to journalReview article

Lincoln, Christie M. ; Fata, Peter ; Sotardi, Susan ; Pohlen, Michael ; Uribe, Tomas ; Bello, Jacqueline A. / Imaging spectrum of immunomodulating, chemotherapeutic and radiation therapy-related intracranial effects. In: British Journal of Radiology. 2018 ; Vol. 91, No. 1082.
@article{aee1a2f63b1b4e3688c84e647c22bf46,
title = "Imaging spectrum of immunomodulating, chemotherapeutic and radiation therapy-related intracranial effects",
abstract = "Objective: A wide range of treatment-related side effects result in specific neurologic symptoms and signs and neuroimaging features. Even to the most seasoned neuroradiologist, elucidating therapy-related side effects from other common mimics can be challenging. We provide a pictorial survey of some common and uncommon medication-induced and therapy-related neuroimaging manifestations, discuss pathophysiology and common pitfalls in imaging and diagnosis. Methods: A case-based review is utilized to depict scenarios on a routine basis in a general radiology or neuroradiology practice such as medication-induced posterior reversible encephalopathy syndrome to the more challenging cases of pseudoprogression and pseudoregression in temozolmide and bevacizumab therapy in gliobastoma treatment protocols. Conclusion: Knowledge of the treatment-induced imaging abnormalities is essential in the accurate interpretation and diagnosis from the most routine to most challenging of clinical situations. We provide a pictorial review for the radiologist to employ in order to be an invaluable provider to our clinical colleagues and patients.",
author = "Lincoln, {Christie M.} and Peter Fata and Susan Sotardi and Michael Pohlen and Tomas Uribe and Bello, {Jacqueline A.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1259/bjr.20170553",
language = "English (US)",
volume = "91",
journal = "British Journal of Radiology",
issn = "0007-1285",
publisher = "British Institute of Radiology",
number = "1082",

}

TY - JOUR

T1 - Imaging spectrum of immunomodulating, chemotherapeutic and radiation therapy-related intracranial effects

AU - Lincoln, Christie M.

AU - Fata, Peter

AU - Sotardi, Susan

AU - Pohlen, Michael

AU - Uribe, Tomas

AU - Bello, Jacqueline A.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective: A wide range of treatment-related side effects result in specific neurologic symptoms and signs and neuroimaging features. Even to the most seasoned neuroradiologist, elucidating therapy-related side effects from other common mimics can be challenging. We provide a pictorial survey of some common and uncommon medication-induced and therapy-related neuroimaging manifestations, discuss pathophysiology and common pitfalls in imaging and diagnosis. Methods: A case-based review is utilized to depict scenarios on a routine basis in a general radiology or neuroradiology practice such as medication-induced posterior reversible encephalopathy syndrome to the more challenging cases of pseudoprogression and pseudoregression in temozolmide and bevacizumab therapy in gliobastoma treatment protocols. Conclusion: Knowledge of the treatment-induced imaging abnormalities is essential in the accurate interpretation and diagnosis from the most routine to most challenging of clinical situations. We provide a pictorial review for the radiologist to employ in order to be an invaluable provider to our clinical colleagues and patients.

AB - Objective: A wide range of treatment-related side effects result in specific neurologic symptoms and signs and neuroimaging features. Even to the most seasoned neuroradiologist, elucidating therapy-related side effects from other common mimics can be challenging. We provide a pictorial survey of some common and uncommon medication-induced and therapy-related neuroimaging manifestations, discuss pathophysiology and common pitfalls in imaging and diagnosis. Methods: A case-based review is utilized to depict scenarios on a routine basis in a general radiology or neuroradiology practice such as medication-induced posterior reversible encephalopathy syndrome to the more challenging cases of pseudoprogression and pseudoregression in temozolmide and bevacizumab therapy in gliobastoma treatment protocols. Conclusion: Knowledge of the treatment-induced imaging abnormalities is essential in the accurate interpretation and diagnosis from the most routine to most challenging of clinical situations. We provide a pictorial review for the radiologist to employ in order to be an invaluable provider to our clinical colleagues and patients.

UR - http://www.scopus.com/inward/record.url?scp=85041372404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041372404&partnerID=8YFLogxK

U2 - 10.1259/bjr.20170553

DO - 10.1259/bjr.20170553

M3 - Review article

VL - 91

JO - British Journal of Radiology

JF - British Journal of Radiology

SN - 0007-1285

IS - 1082

M1 - 20170553

ER -